Improving brain imaging techniques for infants at risk of cerebral palsy
Motion Robust Relaxometry for Infant Neuroimaging
This study is working on new ways to take pictures of babies' brains while they sleep, especially for those who might be at risk for cerebral palsy, to help doctors spot any unusual brain development early on.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10910065 on NIH RePORTER |
What this research studies
This research focuses on developing advanced imaging methods to assess brain changes in infants, particularly those at risk for cerebral palsy. It aims to create faster, quieter, and more motion-robust MRI techniques that can be used while infants are sleeping, minimizing the impact of head movement during scans. By optimizing 3D radial imaging technologies, the study seeks to generate accurate brain imaging maps that can help identify abnormal brain development and tissue differences due to various factors. The ultimate goal is to establish normative data for brain development in infants aged 0 to 2 years, which can be used to better understand and diagnose conditions like cerebral palsy.
Who could benefit from this research
Good fit: Ideal candidates for this research include infants and toddlers aged 0 to 2 years, particularly those at risk for or diagnosed with cerebral palsy.
Not a fit: Patients who are older than 2 years or do not have any risk factors for cerebral palsy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools for identifying brain abnormalities in infants, potentially allowing for earlier interventions for conditions like cerebral palsy.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for brain assessment in young children, indicating that this approach could yield significant advancements.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Alexander, Andrew L — University of Wisconsin-Madison
- Study coordinator: Alexander, Andrew L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.